Literature DB >> 11931377

Cytokines as quality indicators of leucoreduced red cell concentrates.

J Seghatchian1, P Krailadsiri, P Dilger, R Thorpe, M Wadhwa.   

Abstract

Different types of filters are currently used for leucodepletion of red cell concentrates. These filters meet the specification for leucoreduction (<5 x 10(6) leucocytes/ATD) but the quality of the final product may differ depending on the performance of the filters for effective removal of both leucocytes, platelets and possibly cytokines which are associated with transfusion reactions. We measured the levels of three representative cytokines: IL-8, RANTES and TGF-beta1 in red cell concentrates prior to and subsequent to the filtration procedure on day 1 and after a storage period of 35 days. Low levels of IL-8 (10-24 pg/ml) in the control unfiltered concentrates on day 1 which increased by approximately twofold on storage. Filtration reduced the levels of IL-8 on day 1 and day 35, in filtered concentrates in comparison with their control unfiltered counterparts. Leucoreduced concentrates produced by three different filters showed similar IL-8 levels on day 1 and day 35. However, concentrates prepared using another type of process showed a twofold increase in IL-8 levels on storage in comparison with day 1. None of the concentrates tested contained any detectable RANTES and TGF-beta1 suggesting a minimal platelet content. These results indicate that a combination of IL-8, RANTES and TGF-beta1 are useful quality indicators for validation of leucoreduced red cell preparations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11931377     DOI: 10.1016/s1473-0502(01)00144-6

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  2 in total

1.  Pilot analysis of cytokines levels in stored granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell concentrates.

Authors:  Iyonna Woods; Abdul Tawab-Amiri; Karen Byrne; Marianna Sabatino; David F Stroncek
Journal:  Transfusion       Date:  2010-09       Impact factor: 3.157

Review 2.  Red cell transfusions and guidelines: a work in progress.

Authors:  Bruce D Spiess
Journal:  Hematol Oncol Clin North Am       Date:  2007-02       Impact factor: 3.722

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.